The dominant mechanism identified across the medical literature is telogen effluvium , a diffuse, non-scarring shedding condition
Arguments for Game Changer Status Several compelling arguments support the characterization of GLP-1 agonists as transformative therapies: Unprecedented Efficacy : Tirzepatide marks a new era in overweight/obesity treatment, enabling many to achieve 20% weight loss [76] [77]
This can help improve emotional eating and general overeating
The same hair loss occurs with any form of rapid weight loss, whether from bariatric surgery, severe dieting, or illness
Another notable issue is the heterogeneity of metabolism, which could be crucial in treating MASLD
But where brand names like Wegovy and Saxenda are solely focused on mimicking GLP-1 receptors, tirzepatide targets both GLP-1 receptors and another gut hormone known as GIP